The 2nd Asia-Pacific Atrial Fibrillation Symposium
APAFS2006
November 23-25, 2006 Akasaka Prince Hotel, Tokyo Japan
APAFS 2006
Home
Invitation
Organization
Program
Call for Abstract
Registration
Social Program
Hotel / Tours
General Information
Endorsers
Sponsors
Venue & Access
Contact Us
Link
Program
 
Program at a Glance
for print the timetable
November 23 (Thu.)
  2F
  Hall A
(Toukou / Kouun / Kougyoku)
Hall B
(Shiun/Aoba)
7:30    
8:00
Registration hours:
November 23 (Thu.)   14:00 - 20:30
November 24 (Fri.) 7:00 - 19:00
November 23 (Sat.) 7:00 - 17:00
9:00
10:00
11:00
12:00    
13:00    
14:00    
15:00    
    Primary Education Course
16:00  
17:00  
18:00 Present Report as to AF treatment
from Asian Countries
 
19:00  
  President Lecture  
20:00   Welcome Reception
November 24 (Fri.)
  2F 1F
  Hall A
(Toukou / Kouun / Kougyoku)
Hall B
(Shiun / Aoba)
Hall C
(Konjou)
Hall D / Room F
(Shinryoku /
Benibana)
Hall E / Room G
(Sekiei / Koubai)
7:30 Morning Lecture I
Overview of AF ablation
Morning Lecture II
Drug treatment of AF
     
8:00 Symposium I
Drug treatment of AF:
Rate vs. rhythm control and beyond
Case Discussion
Successful ablation cases with various
origins of AF triggers and mechanisms
Exhibition Poster
9:00  
  Live and Video Demonstration
Preferred method at each institution
Panel Discussion I
Frontier of surgical treatment of AF:
Surgeon can lead AF treatment again?
10:00
11:00
  Panel Discussion II
Mechanism and management of atrial fibrillation in Brugada syndrome
12:00
  Luncheon Seminar I
Implantable device therapy for AF
Luncheon Seminar II
Remote navigation
technology for AF ablation
Luncheon Seminar III
Angiotensin (AT1)
receptor and atrial fibrillation
13:00
  Live and Video Demonstration
Preferred method at each institution
Symposium II
Potential role in the development
and maintenance of AF
 
14:00
15:00   Chaired Poster
Presentation
1・2
16:00 Mini-Symposium
New topics in pharmacotherapy of AF:
Is upstream approach effective for treating clinical AF?
Poster
  Evening Lecture
Surgical treatment of AF:
History and advancement
17:00 How to Session I
SVC isolation and its safety
How to Session II
Management of AF in device-implanted patients
 
18:00 Fireside Symposium I
EnSite mapping and NavX system applied
for AF ablation
Fireside Symposium II
New guidance and technology
for AF ablation
 
19:00
November 25 (Sat.)
2F 1F
  Hall A
(Toukou / Kouun / Kougyoku)
Hall B
(Shiun / Aoba)
Hall C
(Konjou)
Hall D / Room F
(Shinryoku /
Benibana)
Hall E
(Sekiei)
Room G
(Koubai)
7:00            
7:30 How to Session III
How to detect and ablate the ligament of Marshall (LOM) focus
Panel Discussion III
Prevention, detection and managements of complication of AF-ablation
8:30
Symposiun III
New insights into chronic AF (CAF)
9:00 Debate I
AF ablation is indicated for asymptomatic paroxysmal AF
Exhibition Poster Poster
 
10:00   Oral Award Presentation Chaired Poster Presentation 3 Poster Award Presentation
11:00 Symposium IV
What is the mechanism for initiation and perpetuation of AF ?
Debate II
Ablate and BiV pacing is superior to curative AF ablation in CAF with heart failure
Oral Presentation Poster Poster
  Debate III
Aggressive ablation strategy is crucial for cure of persistent and permanent AF
12:00
 
  Luncheon Seminar IV
Ablate and bi-ventricular pacing therapy (ABiVPT) for CAF with heart failure
Luncheon Seminar V
Basic and clinical assessment of bepridil
13:00
  Symposium V
Insights into complex fractionated electrogram (CFAE)
Panel Discussion IV
Selection and exclusion of the patients for AF ablation
14:00
15:00 Afternoon Tea Symposium I
Current and future application of CARTO mapping system for AF ablation
Afternoon Tea Symposium II
Balloon technology for AF ablation:
Scientific basis and updated clinical application
16:00 Symposium VI
Treatment of AF in heart failure
 
17:00      
   
18:00
  Gala Dinner        
19:00        
20:00        
>>top
November 23 (Thu.) 15:30-21:30    Hall B
15:30 - 18:00 Primary Education Course

Moderators: Young-Hoon Kim (Seoul, Korea), Kenzo Hirao (Tokyo, Japan)
15:30 - 15:45
I. Video presentation of extensive encircling PV isolation using 2 circular catheters technique
Atsushi Takahashi (Yokosuka, Japan)
II. Lectures
15:45 - 16:10
1. Patient care and evaluation prior to ablation
3D CT of PV/LA
Naoya Tsuboi (Nagoya, Japan)
Trans-thoracic / esophageal echocardiogram
Youichi Kobayashi (Tokyo, Japan)
16:10 - 17:20
2. Ablation procedure
Trans-septal puncture
Heparinization and prevention of thromboembolism
Razali Omar (Kuala Lumpur, Malaysia)
PV angiogram and esophagogram
Arrhythmogenic PV mapping
Teiichi Yamane (Tokyo, Japan)
Internal low-energy cardioversion
Point-by-point ablation following line design for PV disconnection
Masahiko Goya (Kitakyushu, Japan)
3D mapping of LA and PV ostium
Detection and ablation of non-PV foci
Shigeto Naito (Maebashi, Japan)
17:20 - 18:00
3. Follow-up post ablation
Anticoagulation therapy with warfarin
Ming-Hsiung Hsieh (Taipei, Taiwan)
Decision-making of repeated session of AF ablation
Kazuhiro Satomi (Hamburg, Germany)
Follow-up 3D CT and echocardiogram
Satoru Sakagami (Kanazawa, Japan)
Educationally granted by St. Jude Medical
20:00 - 21:30 Welcome Reception

November 23 (Thu.) 18:00-20:00    Hall A
18:00 - 19:30 Present Report as to AF treatment from Asian Countries

Moderators: Masayasu Hiraoka (Tokyo, Japan), Sung Soon Kim (Seoul, Korea)
Panelists:  Jiunn-Lee Lin (Taipei, Taiwan)
Cong-Xin Huang (Wuhan, China)
Young-Hoon Kim (Seoul, Korea)
Muhammad Munawar (Jakarta, Indonesia)
Wee Siong Teo (Mistri Wing, Singapore)
Mohan Nair (New Delhi, India)
Yoshinori Kobayashi (Tokyo, Japan)
19:30 - 20:00 President Lecture

Moderator: Shin-Ann Chen (Taipei, Taiwan)
Japanese contribution to the pathophysiological clarification of atrial fibrillation
President of APAFS2006 Masayasu Hiraoka
>>top
November 24 (Fri.)   7:30-9:30       Hall A
7:30 - 8:00 Morning Lecture I

Moderator: Akihiko Nogami (Yokohama, Japan)
Overview of AF ablation
1. Atrial tachycardia common in AF patients: Its mechanism and treatment
Jonathan Kalman (Melbourne, Australia)
2. Atrial tachycardia after AF ablation: Its mechanism and treatment
Hakan Oral (Michigan, USA)
8:00 - 9:30 Symposium I

Moderators: Sung Soon Kim (Seoul, Korea), Hiroshi Inoue (Toyama, Japan)
Drug treatment of AF: Rate vs. rhythm control and beyond
1. Lessons from the AFFIRM trial
D. George Wyse (Calgary, Canada)
2. Rate or rhythm control: How to tailor therapy for the individual patient
Isabelle Van Gelder (Groningen, The Netherlands)
3. Lessons from J-RHYTHM:
An interim report from the Japanese Society of Electrocardiology
Satoshi Ogawa (Tokyo, Japan)
November 24 (Fri.)   9:30-17:00     Hall A
  9:30 - 12:30
13:30 - 17:00
Live and Video Demonstration

Moderators: Shih-Ann Chen (Taipei, Taiwan), Hans Kottkamp (Leipzig, Germany)
Preferred method at each institution
Live demonstration for paroxysmal and chronic AF
Tsuchiura Kyodo Hospital
Yoshito Iesaka (Tsuchiura, Japan)
Kikuya Uno (Tsuchiura, Japan)
Yasutoshi Nagata (Tsuchiura, Japan)
Kiyoshi Otomo(Tsuchiura, Japan)
Urasoe General Hospital
Shih-Ann Chen (Taipei, Taiwan)
Yenn-Jiang Lin (Taipei, Taiwan)
Satoshi Higa (Okinawa, Japan)
Sugako Ishigaki (Okinawa, Japan)
Ablation video demonstration
1. Young-Hoon Kim (Seoul, Korea)
2. Hakan Oral (Michigan, USA)
3. Koonlawee Nademanee (California, USA)
4. Karl-Heinz Kuck (Hamburg, Germany)
5. Mohan Nair (New Delhi, India)
6. Pierre Jäis (Bordeaux, France)
7. Carlo Pappone (Milan, Italy)
8. Andrea Natale (Ohio, USA)
Supported by St. Jude Medical and Johnson & Johnson
November 24 (Fri.)  12:30-18:00    Hall A
12:30 - 13:20 Luncheon Seminar I

Moderator: Toshiyuki Ishikawa (Yokohama, Japan)
Implantable device therapy for AF
1. Impact of special pacing site and pacing modality on suppression of AF
Chu-Pak Lau (Hong Kong, China)
2. Role of implantable atrial defibrillator for atrial fibrillation
Chun-Chieh Wang (Taipei, Taiwan)
3. Role of devices for atrial fibrillation
Hung-Fat Tse (Hong Kong, China)
Sponsored by St. Jude Medical
17:00 - 18:00 How to Session I

Moderator: You-Ho Kim (Seoul, Korea)
SVC isolation and its safety
1. Structures of arrhythmogenic SVC detected by MRI and MDCT
Hsuan-Ming Tsao (Taipei, Taiwan)
2. Isolation of the superior vena cava
Nassir Marrouche (Utah, USA)
3. EnSite guided superior vena cava isolation in atrial fibrillation ablation:
Technique and results
Hui-Nam Pak (Seoul, Korea)
November 24 (Fri.)  18:00-19:20    Hall A
18:00 - 19:20 Fireside Symposium I

Moderator: Shih-Ann Chen (Taipei, Taiwan)
EnSite mapping and NavX system applied for AF ablation
1. 3D Non-contact mapping of atrial fibrillation: Implication for catheter ablation
Ching-Tai Tai (Taipei, Taiwan)
2. PV isolation and LA substrate ablation using NavX
Young-Hoon Kim (Seoul, Korea)
3. New application of NavX system
Vivek Reddy (Massachusetts, USA)
Sponsored by St. Jude Medical
November 24 (Fri.)    7:30-9:00      Hall B
7:30 - 8:00 Morning Lecture II

Moderator: Mau-Song Chang (Taipei, Taiwan)
Drug treatment of AF
Drug treatment of paroxysmal and persistent atrial fibrillation: Efficacy and clinical significance
Ken Okumura (Hirosaki, Japan)
Sponsored by Astellas Pharma and Toa Eiyo
8:00 - 9:00 Case Discussion

Moderators: Kwok Keung Chan (Hong Kong, China), Kenzo Hirao(Tokyo, Japan)
Successful ablation cases with various origins of AF triggers and mechanisms
Panelists:  Shih-Huang Lee (Taipei,Taiwan),
Razali Omar (Kuala Lumpur, Malaysia),
Shigeto Naito (Maebashi, Japan),
Mitsuhiro Nishizaki (Yokohama, Japan),
Yanzong Yang (Dalian, China)
Cases
1. LA free-wall origin AF
Dong-Gu Shin (Daegu, Korea)
2. SVC origin AF
Shinobu Imai (Tokyo, Japan)
3. CS origin AF
Yanzong Yang (Dalian, China)
4. RA origin AF
Tsu-Juey Wu (Taichung, Taiwan)
5. Focal AF in young
Hung-Fat Tse (Hong Kong, China)
6. Swallowing-induced atrial fibrillation
Hiroshi Tada (Maebashi, Japan)
November 24 (Fri.)    9:30-13:20    Hall B
9:30 - 11:30 Panel Discussion I

Moderators: Yoshio Kosakai (Takarazuka, Japan), Takurou Misaki (Toyama, Japan)
Frontier of surgical treatment of AF: Surgeon can lead AF treatment again?
Panelists:  Masashi Komeda (Kyoto, Japan),
Junjiro Kobayashi (Osaka, Japan)
Jean Ninet (Lyon, France),
Jen-Ping Chang (Kaohsiung, Taiwan)
Chu-Pak Lau (Hong Kong, China),
Nassir Marrouche (Utah, USA)
Jonathan Kalman (Melbourne, Australia)
11:30 - 12:30 Panel Discussion II

Moderator: Toru Ohe (Okayama, Japan)
Mechanism and management of atrial fibrillation in Brugada syndrome
Panelists:  Kengo Kusano (Okayama, Japan),
Yuka Mizusawa (Tokyo, Japan)
Jiunn-Lee Lin (Taipei, Taiwan)
12:30 - 13:20 Luncheon Seminar II

Moderator: Karl-Heinz Kuck (Hamburg, Germany)
Remote navigation technology for AF ablation
1. Stereotaxis: Its benefits and limitations for ablation
Andrea Natale (Ohio, USA)
2. Remote magnetic catheter navigation for circumferential PV ablation
Carlo Pappone (Milan, Italy)
Sponsored by Stereotaxis
November 24 (Fri.)   13:30-17:00    Hall B
13:30 - 15:00 Symposium II

Moderators: Itsuo Kodama (Nagoya, Japan), Chi-Tai Kuo (Taipei,Taiwan)
Potential role in the development and maintenance of AF
1. The role of calcium current in pulmonary vein arrhythmogenesis
Yi-Jen Chen (Taipei, Taiwan)
2. A novel potassium current: Potential role in the development of AF
Tae-Joon Cha (Busan, Korea)
3. Genetic predisposition to the development of atrial fibrillation
Yoshiyasu Aizawa (New York, USA)
4. Endocardial remodeling by atrial fibrillation
Takeshi Yamashita (Tokyo, Japan)
5. Inflammation, oxidative stress, and AF: Mechanistic roles and novel therapeutic approaches
Akiko Shiroshita-Takeshita (Montreal, Canada)
16:00 - 17:00 Mini-Symposium

Moderator: Takeshi Yamashita (Tokyo, Japan)
New topics in pharmacotherapy of AF: Is upstream approach effective for treating clinical AF?
1. Role of renin-angiotensin system blockers in AF patients
From Basic Viewpoint
From Clinical Viewpoint
Yi-Jen Chen (Taipei, Taiwan)
Yoshiyuki Hirayama (Tokyo, Japan)
2. Role of statins in AF patients
From Basic Viewpoint
From Clinical Viewpoint
Koichiro Kumagai (Fukuoka, Japan)
Makoto Suzuki (Chiba, Japan)
November 24 (Fri.)  17:00-19:20     Hall B
17:00 - 17:40 How to Session II

Moderator: Takashi Kurita (Osaka, Japan)
Management of AF in device-implanted patients
1. How to relieve AF burden in CRT/CRT-D patient
Razali Omar (Kuala Lumpur, Malaysia)
2. How to prevent inappropriate shocks due to atrial fibrillation / tachycardia in patients with ICD
Hung-Fat Tse (Hong Kong, China)
Sponsored by Medtronic
18:00 - 19:20 Fireside Symposium II

Moderator: Kaoru Okishige (Yokohama, Japan)
New guidance and technology for AF ablation
1. Technical aspects of energy and catheter selection for safe and effective ablation
Nassir Marrouche (Utah, USA)
2. Progress of GP ablation in AF treatment
Hiroshi Nakagawa (Oklahoma, USA)
3. The Cleveland Clinic approach: Circular mapping catheter-guided pulmonary vein antrum isolation
Andrea Natale (Ohio, USA)
4. Real time MRI guided AF ablation
Henry Halperin (Maryland, USA)
5. Ablation of atypical atrial flutter after AF ablation using 3D mapping approaches
Mark McGuire (Sydney, Australia)
Sponsored by St. Jude Medical
November 24 (Fri.)   12:30-17:00    Hall C
12:30 - 13:20 Luncheon Seminar III

Moderator: Itsuo Kodama (Nagoya, Japan)
Angiotensin (AT1) receptor and atrial fibrillation
Minoru Horie (Shiga, Japan)
Sponsored by Novartis Pharma
16:15 - 17:00 Evening Lecture

Moderator: Fumitaka Isobe (Aichi, Japan)
Surgical treatment of AF: History and advancement
Taijiro Sueda (Hiroshima, Japan)
November 24 (Fri.)   15:00-16:00    Hall E
15:00 - 16:00 Chaired Poster Presentation

Chairs: Toru Iwa (Aichi, Japan), Akihiko Shimizu (Yamaguchi, Japan)
Chaired Poster Presentation 1
  CP1-1 Impact of pulmonary veins isolation on atrial remodeling
Shulong Zhang (Dalian, China)
  CP1-2 The close linkage of arrhythmogenic foci around left superior pulmonary vein
Toshiya Kurotobi (Osaka, Japan)
  CP1-3 Bi-atrial substrate properties in patients with paroxysmal and permanent atrial fibrillation
Shih-Lin Chang (Taipei, Taiwan)
  CP1-4 Predicting risk factors for newly-developed atrial fibrillation in persons who received screening test for general health
Jun Hyung Kim (Seoul, Korea)
  CP1-5 Computed tomographic analysis of the relationship between the esophagus and the left atrium: Characteristics of the closely attached area
Hiroshi Furusho (Kanazawa, Japan)
  CP1-6 Three-dimensional frequency map by magnetocardiography indicates a predictive value for the restoration to sinus rhythm after surgical pulmonary vein isolation
Kenji Nakai (Morioka, Japan)
  CP1-7 Plasma brain natriuretic peptide(BNP) levels to predict paroxysmal atrial fibrillation(AF) in patients with hypertrophic cardiomyopathy(HCM)
Takashi Murakami (Okayama, Japan)
  CP1-8 Significant changes of P wave-triggered signal-averaged atrial electrocardiogram after extensive pulmonary vein isolation in patients with atrial fibrillation
Kazuyuki Tanoue (Tsukuba, Japan)
 
November 24 (Fri.)  15:00-16:00    Room G
15:00 - 16:00 Chaired Poster Presentation

Chairs: Minoru Horie (Shiga, Japan), Kyoko Soejima (Tokyo, Japan)
Chaired Poster Presentation 2
  CP2-1 Efficacy and safety of right atrial septal pacing in patients with sinus node dysfunction
Miki Yokokawa (Maebashi, Japan)
  CP2-2 Incidence and characteristics of inappropriate therapies due to atrial fibrillation or atrial flutter in patients with implantable cardioverter defibrillator
Takashi Noda (Suita, Japan)
  CP2-3 Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers to the atrial fibrillation in permanent pacemaker recipients
Sang Rok Lee (Gwang ju, Korea)
  CP2-4 Possible mechanism for the termination of paroxysmal atrial fibrillation by pilsicainide
Eriko Yokoyama (Shizuoka, Japan)
  CP2-5 Relationships between sex hormones and atrial fibrillation: Protective effects of testosterone in rat atria
Takayuki Tsuneda (Tokyo, Japan)
  CP2-6 Aging alters arrhythmogenesis and calcium regulations in pulmonary veins: implications in the genesis of atrial fibrillation
Wanwarang Wongcharoen (Taipei, Taiwan)
  CP2-7 Protective effects of pravastatin on endocardial remodeling in rapidly paced rat atria
Takeshi Kato (Tokyo, Japan)
  CP2-8 Effects of Carvedilol on atrial gap junctional remodeling after myocardial infarction
Feng Cao (Wuhan, China)
>>top
November 25 (Sat.)    7:30-10:00    Hall A
7:30 - 8:30 How to Session III

Moderator: Hiroshi Nakagawa (Oklahoma, USA)
How to detect and ablate the ligament of Marshall (LOM) focus
1. Anatomy of the ligament of Marshall
Shin Inoue (Tokyo, Japan)
2. Electrophysiology of the ligament of Marshall
Peng-Sheng Chen (California, USA)
3. Ablation of ligament of Marshall in atrial fibrillation
Chun Hwang (Utah, USA)
8:30 - 10:00 Symposium III

Moderators: Douglas L. Packer (Minnesota, USA), Jonathan Kalman (Melbourne, Australia)
New insights into chronic AF (CAF)
1. Sequential ablation approach to permanent AF
Pierre Jäis (Bordeaux, France)
2. Structural changes of left atrium in chronic atrial fibrillation
Osamu Igawa (Tottori, Japan)
3. Electrophysiologic properties in the atria, thoracic veins and autonomic nerves in chronic atrial fibrillation
Peng-Sheng Chen (California, USA)
4. New insights into mechanism of CAF by multielectrode mapping
Maurits Allessie (Maastricht, The Netherlands)
5. New insights into mechanism of CFAE by point by point mapping
Koonlawee Nademanee (California, USA)
November 25 (Sat.)  11:00-12:30    Hall A
11:00 - 12:30 Symposium IV

Moderators: Peng-Sheng Chen (California, USA), Masayasu Hiraoka (Tokyo, Japan)
What is the mechanism for initiation and perpetuation of AF ?
1. Involvement of pulmonary veins in the pathogenesis of atrial fibrillation
Itsuo Kodama (Nagoya, Japan)
2. Heterogeneous pulmonary vein myocardial cell repolarization:
Implication for reentry and triggered activity
Yasushi Miyauchi (Tokyo, Japan)
3. Effect of the autonomic tone on PV origin atrial fibrillation is not the same in normal heart dogs and chronic AV block dogs
Kenzo Hirao (Tokyo, Japan)
4. PV-LA reentry in human
Koichiro Kumagai (Fukuoka, Japan)
5. AF initiation and maintenance mechanism disclosed by catheter ablation
Hakan Oral (Michigan, USA)
November 25 (Sat.)  12:30-15:00    Hall A
12:30 - 13:20 Luncheon Seminar IV

Moderator: Wee Siong Teo (Mistri Wing, Singapore)
Ablate and bi-ventricular pacing therapy (ABiVPT) for CAF with heart failure
1. Bi-ventricular pacing for chronic atrial fibrillation
David O’Donnell (Victoria, Australia)
2. Ablation and bi-ventricular pacing therapy (ABiVPT) for CAF with heart failure: Benefits and limitations of ABiVPT
Kazuo Matsumoto (Saitama, Japan)
Sponsored by St. Jude Medical
13:30 - 15:00 Symposium V

Moderators: Koonlawee Nademanee (California, USA), Takanori Ikeda (Tokyo, Japan)
Insights into complex fractionated electrogram (CFAE)
1. Electrophysiological basis of CFAE: Is it a marker of optimal target site for AF ablation?
Maurits Allessie (Maastricht, The Netherlands)
2. FFT analysis can identify AF substrate in AF
Ching-Tai Tai (Taipei, Taiwan)
3. Spectral analysis and DF mapping to detect CFAE
Prashanthan Sanders (Adelaide, Australia)
4. Autonomic mechanism to explain intermittent and continuous complex fractionated atrial electrograms
Sunny Po (Oklahoma, USA)
5. Hybrid strategies for ablation of permanent AF as an adjunct to PVI:
Implications of targeting AF NEST in sinus rhythm and CFAE in AF
Mauricio Arruda (Ohio, USA)
November 25 (Sat.)  15:00-16:00    Hall A
15:00 - 16:00 Afternoon Tea Symposium I

Moderator: Karl-Heinz Kuck (Hamburg, Germany)
Current and future application of CARTO mapping system for AF ablation
1. Electroanatomy-guided circumferential PV isolation using CARTO map and double Lasso technique
Kikuya Uno (Tsuchiura, Japan)
2. Three-dimensional dominant frequency mapping using CARTO for AF ablation
Prashanthan Sanders (Adelaide, Australia)
3. Image integration using the CARTO MERGE module
David Callans (Pennsylvania, USA)
Sponsored by Johnson & Johnson
November 25 (Sat.)  16:00-17:30    Hall A
16:00 - 17:30 Symposium VI

Moderators: Chu-Pak Lau (Hong Kong, China), Kazutaka Aonuma (Tsukuba, Japan)
Treatment of AF in heart failure
1. How to attain rhythm control pharmacologically in AF patients with heart failure, if it is required?
Isabelle Van Gelder (Groningen, The Netherlands)
2. Catheter ablation for cure of atrial fibrillation in heart failure can improve left ventricular and left atrial function
Li-Fern Hsu (Mistri Wing, Singapore)
3. Clinical outcomes of catheter ablation of atrial fibrillation in patients with depressed ventricular function and heart failure
Koonlawee Nademanee (California, USA)
4. A tiered approach for lesion creation in radiofrequency catheter ablation for chronic rheumatic atrial fibrillation: Initial results
Mohan Nair (New Delhi, India)
5. The Role of AV-node ablation and BiV pacing on improvement of morbidity and mortality of AF patient in heart failure
Andrea Natale (Ohio, USA)
November 25 (Sat.)   7:30-11:40     Hall B
16:00 - 17:30 Panel Discussion III

Moderator: San-Jou Yeh (Taoyuan, Taiwan)
Prevention, detection and managements of complication of AF-ablation
Issues
1. PV stenosis
Douglas Packer (Minnesota, USA)
2. Atrio-esophageal fistula
Hans Kottkamp (Leipzig, Germany)
3. Peri-esophageal vagal nerve damage
Atsushi Takahashi (Yokosuka, Japan)
4. AT post ablation
Shu Zhang (Beijing, China)
5. Thrombo-embolism, air-embolism
Kee-Joon Choi (Seoul, Korea)
6. Cardiac tamponade
Tachapong Ngarmukos (Bangkok, Thailand)
9:00 - 9:40 Debate I

Moderator: Muhammad Munawar (Jakarta, Indonesia)
AF ablation is indicated for asymptomatic paroxysmal AF
Protagonist: Seil Oh (Seoul, Korea)
Antagonist: Shigeru Ikeguchi (Shiga, Japan)
11:00 - 11:40 Debate II

Moderator: Yoshinori Kobayashi (Tokyo, Japan)
Ablate and BiV pacing is superior to curative AF ablation in CAF with heart failure
Protagonist: Ming-Hsiung Hsieh (Taipei, Taiwan)
Antagonist: Yoshito Iesaka (Tsuchiura, Japan)
November 25 (Sat.)  11:40-15:00    Hall B
11:40 - 12:20 Debate III

Moderator: Yoshito Iesaka (Tsuchiura, Japan)
Aggressive ablation strategy is crucial for cure of persistent and permanent AF
Protagonist: Hans Kottkamp (Leipzig, Germany)
Antagonist: Karl-Heinz Kuck (Hamburg, Germany)
12:30 - 13:20 Luncheon Seminar V

Moderator: Kaoru Sugi (Tokyo, Japan)
Basic and clinical assessment of bepridil
1. Actions of bepridil as an antiarrhythmic drug
Katsushige Ono (Oita, Japan)
2. Clinical efficacy of bepridil for persistent atrial fibrillation
Yuji Nakazato (Tokyo, Japan)
Sponsored by Sankyo
13:30 - 15:00 Panel Discussion IV

Moderator: Chun Hwang (Utah, USA)
Selection and exclusion of the patients for AF ablation
Panelists:  David Callans (Pennsylvania, USA),
Teiichi Yamane (Tokyo, Japan),
Wee Siong Teo (Mistri Wing, Singapore),
Yong-Seog Oh (Seoul, Korea),
Chang-Sheng Ma (Beijing, China)
Issues
1. Asymptomatic paroxysmal AF
2. Rare and long-lasting paroxysmal AF
3. Chronic asymptomatic AF
4. Aged patients >70 - 80 yrs old
5. Significant left ventricular dysfunction
6. Valvular heart disease with indication for surgery
7. Dilated LA
November 25 (Sat.)  15:00-16:00    Hall B
15:00 - 16:00   Afternoon Tea Symposium II

Moderators: Hiroshi Nakagawa (Oklahoma, USA), Shutaro Satake (Kanagawa, Japan)
Balloon technology for AF ablation: Scientific basis and updated clinical application
1. Various balloon ablation technology: Benefits and limitations
Douglas Packer (Minnesota, USA)
2. Cryothermal balloon
Vivek Reddy (Massachusetts, USA)
3. A radiofrequency hot balloon
Shutaro Satake (Kanagawa, Japan)
4. Initial experience using a forward directed, high-intensity focused ultrasound balloon catheter for pulmonary vein antrum isolation in patients with atrial fibrillation
Hiroshi Nakagawa (Oklahoma, USA)
November 25 (Sat.)  18:30-20:00    Hall A, B
18:30 - 20:00   Gala Dinner

>>top
contact
Secretariat of APAFS2006
c/o ICS Convention Design, Inc.
Sumitomo Corp. Jinbocho Bldg.
3-24, Kanda-Nishikicho, Chiyoda-ku, Tokyo 101-8449, Japan
TEL: +81-3-3219-3541
FAX: +81-3-3292-1811
E-mail: apafs2006@ics-inc.co.jp
COPYRIGHT (C) APAFS2006 ALL RIGHT RESERVED.